IDiyas

For the Inventor, By the Inventor

Brussels, Belgium

Michael John Scott Saunders

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 6.4

ph-index = 7

Forward Citations = 201(Granted Patents)


Company Filing History:

goldMedal16 out of 163 
 
Ablynx N.v.
 patents
silverMedal3 out of 2,937 
 
Merck Patent Gmbh
 patents
bronzeMedal2 out of 28 
 
Argenx Bv
 patents
4. 2 out of 11 
 
Argen-x N.v.
 patents
5. 1 out of 13 
 
Argenx Bvba
 patents

Years Active: 2013-2024

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents
1. 11858997 - Amino acid sequences that modulate the interaction between cells of the immune system (2024-01-02),
2. 11773159 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same (2023-10-03),
3. 11434298 - Antibodies to CD70 (2022-09-06),
4. 11072665 - Antibodies to CD70 (2021-07-27),
5. 10844123 - Amino acid sequences that modulate the interaction between cells of the immune system (2020-11-24),
6. 10829552 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same (2020-11-10),
7. 10208115 - Amino acid sequences that modulate the interaction between cells of the immune system (2019-02-19),
8. 10087251 - Amino acid sequences that modulate the interaction between cells of the immune system (2018-10-02),
9. 10017568 - Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using same (2018-07-10),
10. 9822175 - Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis (2017-11-21),
11. 9803018 - Amino acid sequences directed against cellular receptors for viruses and bacteria (2017-10-31),
12. 9765149 - Antibodies to CD70 (2017-09-19),
13. 9765148 - Antibodies to CD70 (2017-09-19),
14. 9512236 - Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders (2016-12-06),
15. 9382333 - Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis (2016-07-05),

Title: The Innovative Journey of Michael John Scott Saunders

Introduction:

Michael John Scott Saunders is a visionary inventor based in Brussels, Belgium. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of technology through his inventive spirit and dedication to progress.

Latest Patents:

Michael John Scott Saunders holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology. His innovative ideas have led to the development of cutting-edge products that have revolutionized their respective industries.

Career Highlights:

Throughout his illustrious career, Michael John Scott Saunders has worked with leading tech companies and research institutions to bring his inventions to life. His expertise in patent law and his keen eye for detail have ensured that his creations are protected and recognized on a global scale.

Collaborations:

Michael John Scott Saunders has collaborated with top engineers, scientists, and designers to enhance the impact of his inventions. By fostering a culture of innovation and teamwork, he has been able to push the boundaries of what is possible in the world of technology.

Conclusion:

In conclusion, Michael John Scott Saunders stands as a beacon of creativity and ingenuity in the field of invention. His relentless pursuit of innovation and his commitment to excellence continue to inspire the next generation of inventors to dream big and create a better future for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…